REG - Weir Group PLC - Director/PDMR Shareholding

WeirAnnouncement

14/05/2025 11:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250514:nRSN6629Ia&default-theme=true

RNS Number : 6629I  Weir Group PLC  14 May 2025

14 May 2025

The Weir Group PLC

 

Notification of Transactions by Persons Discharging Managerial
Responsibilities ("PDMR") and Persons Closely Associated ("PCA") with them.

The Weir Group PLC (the "Company") hereby announces that Rachel Stanton, PCA
of Jon Stanton (PDMR), has transferred ordinary shares of 12.5 each in the
Company from her existing nominee account provider to a new nominee account
provider for nil consideration, as described in more detail below.

Following the transfer, the beneficial shareholding of each of Jon and Rachel
Stanton remains unchanged.

This notification relates to a transaction notified in accordance with the UK
Market Abuse Regulation, further details below:

 

 1.    Details of the person discharging managerial responsibilities/ person closely
       associated
 a)    Name

                                                                                                                                                                  Rachel Stanton

 2.    Reason for the notification
 a)    Position/status                                                                                                                                            PCA. Spouse of Jon Stanton, PDMR
 b)    Initial notification/ Amendment                                                                                                                            Initial Notification
 3.    Details of the issuer, emission allowance market participant, auction
       platform, auctioneer or auction monitor
 a)    Name                                                                                                                                                       The Weir Group PLC
 b)    LEI                                                                                                                                                        549300KDR56WHY9I3D10
 4.    Details of the transaction(s): section to be repeated for (i) each type of
       instrument; (ii) each type of transaction; (iii) each date; (iv) each place
       where transactions have been conducted
 a)    Description of the financial instrument, type of instrument      Ordinary shares of 12.5p each fully paid

                             Identification code

                                                                        GB0009465807

 b)    Nature of the transaction                                        Transfer of 117,945 ordinary shares in the Company from Rachel Stanton's
                                                                        existing nominee account provider (Stocktrade) to a new nominee account
                                                                        provider (LGT), with no change in ultimate beneficial ownership
  c)   Price(s) and volume(s)                                           Price(s)  Volume(s)

                                                                Nil       117,945

 

 d)    Aggregated information                                           N/A Single transaction

       -     Aggregated volume

       -     Price
 e)    Date of the transaction                                          8 April 2025
 f)    Place of the transaction                                         Outside a trading venue.

 

 

d)

Aggregated information

-     Aggregated volume

-     Price

N/A Single transaction

e)

Date of the transaction

8 April 2025

f)

Place of the transaction

Outside a trading venue.

For further information, please contact:

 

Jennifer Haddouk

Company Secretary

Telephone: 0141 308 3771

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHAIMMTMTTBBFA